Literature DB >> 2205380

Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line.

A Rosolen1, L Whitesell, N Ikegaki, R H Kennett, L M Neckers.   

Abstract

The N-myc gene is transiently expressed during normal embryonic development and abnormally expressed in several tumors of neuroendocrine origin. Little is known of the function of the N-myc gene product in either normal or neoplastic tissue. We utilized synthetic antisense oligodeoxynucleotides to specifically inhibit N-myc gene expression in the neuroepithelioma cell line CHP100. These cells contain single copy N-myc alleles but overexpress c-myc. N-myc antisense oligomer treatment was found to be growth inhibitory without affecting levels of c-myc protein. N-myc antisense oligomer-treated cells also lost the characteristic cellular heterogeneity displayed by CHP100 in vitro.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2205380

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Episome-generated N-myc antisense RNA restricts the differentiation potential of primitive neuroectodermal cell lines.

Authors:  L Whitesell; A Rosolen; L M Neckers
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

Review 2.  Biology of pediatric peripheral neuroectodermal tumors.

Authors:  C J Thiele
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

3.  erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.

Authors:  R Colomer; R Lupu; S S Bacus; E P Gelmann
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.